Adial Pharmaceuticals, Inc.
ADIL · NASDAQ
Bulios Fair Price
$3.66
16.8% downside
Trenutna cena
$4.4
Po podatkih Bulios Fair Price je delnica ADIL trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
O podjetju
Adial Pharmaceuticals (ADIL) is a pharmaceutical company focused on the development and commercialization of medications for the treatment of addictions and other disorders related to the central nervous system. The company specializes in researching innovative treatment methods aimed at helping patients overcome addictions and improve their quality of life. Adial Pharmaceuticals is known for its advanced clinical trials and commitment to providing effective therapeutic options. Adial Pharmaceuticals (ADIL) shares could be suitable for investors looking for opportunities in the biotechnology and pharmaceutical research sectors focused on addiction treatment.
V vašem jeziku še ni na voljo, zato je besedilo v angleščini.
Sector
Healthcare
Industry
Biotechnology
CEO
Cary John Claiborne
Employees
5
Headquarters
Glen Allen
Prihajajoči dogodki
Earnings
Upcoming earnings report